Desmosterol accumulation in users of amiodarone
- 21 September 2017
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 283 (1) , 93-101
Abstract
Background: Amiodarone is an effective and widely used antiarrhythmic drug with many possible adverse effects including hypercholesterolaemia and hepatotoxicity.Objective: Our aim was to evaluate how long‐term amiodarone treatment affects cholesterol metabolism.Methods: The study population consisted of 56 cardiac patients, of whom 20 were on amiodarone (amiodarone + group) and 36 did not use the drug (amiodarone − group). We also studied a control group of 124 individuals selected randomly from the population. Cholesterol metabolism was evaluated by analysis of serum noncholesterol sterols by gas–liquid chromatography and gas chromatography–mass spectrometry.Results: Comparisons of serum lipids and noncholesterol sterols across the three groups showed increased serum triglyceride in users of amiodarone but no statistically significant group differences in total, LDL or HDL cholesterol or serum proprotein convertase subtilisin/kexin type 9 concentrations. Nor did the groups differ in the ratios of cholestanol or plant sterols to cholesterol in serum, suggesting that cholesterol absorption was unaltered. However, all users of amiodarone had very markedly elevated serum desmosterol concentrations: the desmosterol‐to‐cholesterol ratio (102 × μmol mmol−1) averaged 1030.7 ± 115.7 (mean ± SE) in the amiodarone + group versus 82.7 ± 3.4 and 75.9 ± 1.4 in the amiodarone − and the population control groups (P < 0.001), respectively.Conclusion: Use of amiodarone was associated with on average 12‐fold serum desmosterol concentrations compared with the control groups. This observation is fully novel and suggests that amiodarone interferes with the conversion of desmosterol to cholesterol in the cholesterol synthesis pathway. Whether accumulation of desmosterol plays a role in amiodarone‐induced hepatotoxicity deserves to be studied in the future.Keywords
This publication has 35 references indexed in Scilit:
- Desmosterol in Human Nonalcoholic SteatohepatitisHepatology, 2013
- Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined ImmunosuppressionCirculation: Heart Failure, 2013
- Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver DiseaseCell Metabolism, 2012
- Phospholipidosis in Rats Treated with Amiodarone: Serum Biochemistry and Whole Genome Micro-Array Analysis Supporting the Lipid Traffic Jam Hypothesis and the Subsequent Rise of the Biomarker BMPToxicologic Pathology, 2012
- Desmosterolosis—phenotypic and molecular characterization of a third case and review of the literatureAmerican Journal of Medical Genetics Part A, 2011
- The desmosterolosis phenotype: spasticity, microcephaly and micrognathia with agenesis of corpus callosum and loss of white matterEuropean Journal of Human Genetics, 2011
- The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetesAtherosclerosis, 2008
- Amiodarone-Induced Changes in Lipid MetabolismHormone and Metabolic Research, 1990
- Elevation of serum total cholesterol and triglyceride levels during amiodarone therapyThe American Journal of Cardiology, 1988
- Serum squalene and methyl sterols as indicators of cholesterol synthesisLife Sciences, 1969